SolAeroMed
Calgary
About SolAeroMed
SolAeroMed is a developer of a novel therapeutic used to treat obstructive lung diseases such as cystic fibrosis, bronchiectasis, asthma rescue drug, and other chronic obstructive lung diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $101.0K
- Funding stage: Seed
- Last round: Angel (Sep 2016)
- Website: solaeromed.com
- Phone: 403-969-7999
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/solaeromed-2423366 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.